Nutex Health reported first quarter revenue of $216.5 million, up 2.2% year-over-year, driven by a 1.8% rise in hospital division revenue. Net income attributable to the company climbed 120.6% to $46.8 million, with diluted EPS of $6.52, while adjusted EBITDA reached $57.6 million and operating cash flow totaled $75.5 million.

Total visits at the hospital division rose 3.1% to 49,742, with same-hospital visits up 0.6%. A meaningful portion of revenue was supported by higher acuity claims and the Independent Dispute Resolution process, where the company submits 50–60% of claims and prevails in over 85% of determinations.

As of March 31, 2026, Nutex Health held $207.3 million in cash and cash equivalents, up from $185.6 million at year-end 2025. Net long-term debt decreased to $24.3 million from $29.2 million, strengthening the balance sheet and liquidity position.

The company remains on track to open three new hospitals later this year and has board approval to selectively self-develop new facilities through its real estate division. This strategic investment underscores management’s confidence in sustaining a development pace of three to five hospitals annually.